Regulatory Resources
Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools
30-Day Notices, 135-Day PMA Supplements and 75-Day HDE Supplements for Manufacturing Changes
Final FDA guidance on pma. Published 2019 by CDRH/CBER.
Download PDFAcceptance and Filing Reviews for Premarket Approval Applications (PMAs)
Final FDA guidance on pma. Published 2019 by CDRH/CBER.
Download PDFDeveloping and Labeling In Vitro Companion Diagnostic Devices for Oncology Therapeutic Products
Final FDA guidance on ivd & diagnostics. Published 2020 by CDRH/CBER.
Download PDFNonbinding Feedback After Certain FDA Inspections of Device Establishments
Final FDA guidance on inspections. Published 2020 by CDRH/CBER.
Download PDFProviding Regulatory Submissions for Medical Devices in Electronic Format — Section 745A(b)
Final FDA guidance on submission process. Published 2020 by CDRH/CBER.
Download PDFReview and Update of Device Establishment Inspection Processes and Standards
Final FDA guidance on inspections. Published 2020 by CDRH/CBER.
Download PDFRecognition and Withdrawal of Voluntary Consensus Standards
Final FDA guidance on standards & conformity. Published 2020 by CDRH/CBER.
Download PDFMultiple Function Device Products: Policy and Considerations
Final FDA guidance on classification. Published 2020 by CDRH/CBER.
Download PDFSafer Technologies Program for Medical Devices (STeP)
Final FDA guidance on breakthrough devices. Published 2021 by CDRH/CBER.
Download PDFAcceptance Review for De Novo Classification Requests
Final FDA guidance on de novo. Published 2021 by CDRH/CBER.
Download PDF